Iovance Biotherapeutics, Inc. (LON:0JDK)
London · Delayed Price · Currency is GBP · Price in USD 2.021
-0.189 (-8.53%)
At close: Oct 29, 2025
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of 536.75 million as of October 31, 2025. Its market cap has decreased by -75.86% in one year.
Market Cap
536.75M
Enterprise Value
348.09M
Revenue
176.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.02
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 536.75M, an increase of 760.35%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 536.75M | -70.21% |
| Dec 31, 2024 | 1.80B | 10.29% |
| Dec 29, 2023 | 1.63B | 95.13% |
| Dec 30, 2022 | 837.09M | -62.16% |
| Dec 31, 2021 | 2.21B | -55.63% |
| Dec 31, 2020 | 4.99B | 89.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.77B |
| GSK plc | 70.40B |
| Haleon | 30.72B |
| Smith & Nephew | 11.60B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.04B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.68B |